x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 91-1962278 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
3003 Tasman Drive, Santa Clara, California | 95054-1191 | |
(Address of principal executive offices) | (Zip Code) |
Page | ||
Item 1. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
(Dollars in thousands, except par value and share data) | June 30, 2017 | December 31, 2016 | ||||||
Assets | ||||||||
Cash and cash equivalents | $ | 3,854,244 | $ | 2,545,750 | ||||
Available-for-sale securities, at fair value (cost of $12,053,305 and $12,588,783, respectively) | 12,071,052 | 12,620,411 | ||||||
Held-to-maturity securities, at cost (fair value of $9,910,504 and $8,376,138, respectively) | 9,938,371 | 8,426,998 | ||||||
Non-marketable and other securities | 630,670 | 622,552 | ||||||
Total investment securities | 22,640,093 | 21,669,961 | ||||||
Loans, net of unearned income | 20,976,466 | 19,899,944 | ||||||
Allowance for loan losses | (236,496 | ) | (225,366 | ) | ||||
Net loans | 20,739,970 | 19,674,578 | ||||||
Premises and equipment, net of accumulated depreciation and amortization | 121,947 | 120,683 | ||||||
Accrued interest receivable and other assets | 1,044,125 | 672,688 | ||||||
Total assets | $ | 48,400,379 | $ | 44,683,660 | ||||
Liabilities and total equity | ||||||||
Liabilities: | ||||||||
Noninterest-bearing demand deposits | $ | 35,046,371 | $ | 31,975,457 | ||||
Interest-bearing deposits | 7,418,920 | 7,004,411 | ||||||
Total deposits | 42,465,291 | 38,979,868 | ||||||
Short-term borrowings | 470 | 512,668 | ||||||
Other liabilities | 1,145,154 | 618,383 | ||||||
Long-term debt | 749,429 | 795,704 | ||||||
Total liabilities | 44,360,344 | 40,906,623 | ||||||
Commitments and contingencies (Note 12 and Note 15) | ||||||||
SVBFG stockholders’ equity: | ||||||||
Preferred stock, $0.001 par value, 20,000,000 shares authorized; no shares issued and outstanding | — | — | ||||||
Common stock, $0.001 par value, 150,000,000 shares authorized; 52,684,159 shares and 52,254,074 shares outstanding, respectively | 53 | 52 | ||||||
Additional paid-in capital | 1,283,485 | 1,242,741 | ||||||
Retained earnings | 2,601,007 | 2,376,331 | ||||||
Accumulated other comprehensive income | 14,890 | 23,430 | ||||||
Total SVBFG stockholders’ equity | 3,899,435 | 3,642,554 | ||||||
Noncontrolling interests | 140,600 | 134,483 | ||||||
Total equity | 4,040,035 | 3,777,037 | ||||||
Total liabilities and total equity | $ | 48,400,379 | $ | 44,683,660 |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(Dollars in thousands, except per share amounts) | 2017 | 2016 | 2017 | 2016 | ||||||||||||
Interest income: | ||||||||||||||||
Loans | $ | 250,197 | $ | 205,287 | $ | 477,538 | $ | 403,229 | ||||||||
Investment securities: | ||||||||||||||||
Taxable | 95,522 | 86,603 | 185,325 | 177,653 | ||||||||||||
Non-taxable | 885 | 575 | 1,531 | 1,171 | ||||||||||||
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities | 7,323 | 1,527 | 10,459 | 3,597 | ||||||||||||
Total interest income | 353,927 | 293,992 | 674,853 | 585,650 | ||||||||||||
Interest expense: | ||||||||||||||||
Deposits | 2,197 | 1,261 | 3,914 | 2,449 | ||||||||||||
Borrowings | 9,034 | 9,395 | 18,250 | 18,444 | ||||||||||||
Total interest expense | 11,231 | 10,656 | 22,164 | 20,893 | ||||||||||||
Net interest income | 342,696 | 283,336 | 652,689 | 564,757 | ||||||||||||
Provision for credit losses (1) | 15,806 | 36,746 | 46,540 | 70,221 | ||||||||||||
Net interest income after provision for credit losses | 326,890 | 246,590 | 606,149 | 494,536 | ||||||||||||
Noninterest income: | ||||||||||||||||
Gains on investment securities, net | 17,630 | 23,270 | 33,600 | 18,586 | ||||||||||||
Gains on equity warrant assets, net (2) | 10,820 | 5,089 | 17,510 | 11,695 | ||||||||||||
Foreign exchange fees | 26,108 | 24,088 | 52,355 | 51,054 | ||||||||||||
Credit card fees | 18,099 | 15,424 | 35,829 | 30,931 | ||||||||||||
Deposit service charges | 14,563 | 13,114 | 28,538 | 25,786 | ||||||||||||
Client investment fees | 12,982 | 8,012 | 22,008 | 16,007 | ||||||||||||
Lending related fees | 8,509 | 7,802 | 17,470 | 15,615 | ||||||||||||
Letters of credit and standby letters of credit fees | 7,006 | 6,014 | 13,645 | 11,603 | ||||||||||||
Other (2) | 12,811 | 9,963 | 25,232 | 17,633 | ||||||||||||
Total noninterest income | 128,528 | 112,776 | 246,187 | 198,910 | ||||||||||||
Noninterest expense: | ||||||||||||||||
Compensation and benefits | 148,973 | 115,580 | 296,149 | 237,842 | ||||||||||||
Professional services | 27,925 | 25,516 | 53,344 | 44,516 | ||||||||||||
Premises and equipment | 18,958 | 16,586 | 34,816 | 31,570 | ||||||||||||
Net occupancy | 11,126 | 9,359 | 22,777 | 19,394 | ||||||||||||
Business development and travel | 11,389 | 9,327 | 20,584 | 21,573 | ||||||||||||
FDIC and state assessments | 9,313 | 6,892 | 17,995 | 13,819 | ||||||||||||
Correspondent bank fees | 3,163 | 2,713 | 6,608 | 6,365 | ||||||||||||
Other | 20,399 | 13,966 | 36,606 | 28,759 | ||||||||||||
Total noninterest expense (1) | 251,246 | 199,939 | 488,879 | 403,838 | ||||||||||||
Income before income tax expense | 204,172 | 159,427 | 363,457 | 289,608 | ||||||||||||
Income tax expense (3) | 71,656 | 65,047 | 123,061 | 118,631 | ||||||||||||
Net income before noncontrolling interests | 132,516 | 94,380 | 240,396 | 170,977 | ||||||||||||
Net (income) loss attributable to noncontrolling interests | (9,323 | ) | (1,416 | ) | (15,720 | ) | 1,161 | |||||||||
Net income available to common stockholders (3) | $ | 123,193 | $ | 92,964 | $ | 224,676 | $ | 172,138 | ||||||||
Earnings per common share—basic (3) | $ | 2.34 | $ | 1.79 | $ | 4.28 | $ | 3.33 | ||||||||
Earnings per common share—diluted (3) | 2.32 | 1.78 | 4.22 | 3.30 |
(1) | Our consolidated statements of income for the three and six months ended June 30, 2016 were modified from prior period's presentation to conform to the current period's presentation, which reflects our provision for loan losses and provision for unfunded credit commitments together as our “provision for credit losses”. In prior periods, our provision for unfunded credit commitments were reported as a component of noninterest expense. |
(2) | Our consolidated statements of income for the three and six months ended June 30, 2016 were modified from prior period's presentation to conform to the current period's presentation, which reflects a new line item to separately disclose net gains on equity warrant assets. In prior periods, net gains on equity warrant assets were reported as a component of gains on derivative instruments, net. We removed the line item gains on derivative instruments, net and reclassified all other gains on derivative instruments, net to other noninterest income. |
(3) | Included in income tax expense, net income available to common shareholders, earnings per common share-basic and earnings for common share-diluted, for the three and six months ended June 30, 2017, are tax benefits recognized associated with the adoption of Accounting Standards Update (“ASU”) 2016-09, Improvements to Employee Share-Based Payment Accounting in the first quarter of 2017. This guidance was adopted on a prospective basis with no change to prior period amounts. |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(Dollars in thousands) | 2017 | 2016 | 2017 | 2016 | ||||||||||||
Net income before noncontrolling interests | $ | 132,516 | $ | 94,380 | $ | 240,396 | $ | 170,977 | ||||||||
Other comprehensive (loss) income, net of tax: | ||||||||||||||||
Change in cumulative translation gains (losses): | ||||||||||||||||
Foreign currency translation gains (losses) | 1,578 | (1,795 | ) | 2,535 | (2,049 | ) | ||||||||||
Related tax (expense) benefit | (644 | ) | 731 | (1,034 | ) | 835 | ||||||||||
Change in unrealized (losses) gains on available-for-sale securities: | ||||||||||||||||
Unrealized holding (losses) gains | (5,639 | ) | 40,937 | (13,396 | ) | 211,768 | ||||||||||
Related tax benefit (expense) | 2,500 | (16,686 | ) | 5,636 | (86,289 | ) | ||||||||||
Reclassification adjustment for losses (gains) included in net income | 123 | (12,328 | ) | (485 | ) | (11,582 | ) | |||||||||
Related tax (benefit) expense | (50 | ) | 5,017 | 198 | 4,713 | |||||||||||
Amortization of unrealized gains on securities transferred from available-for-sale to held-to-maturity | (1,566 | ) | (2,250 | ) | (3,337 | ) | (4,817 | ) | ||||||||
Related tax benefit | 630 | 905 | 1,343 | 1,938 | ||||||||||||
Other comprehensive (loss) income, net of tax | (3,068 | ) | 14,531 | (8,540 | ) | 114,517 | ||||||||||
Comprehensive income | 129,448 | 108,911 | 231,856 | 285,494 | ||||||||||||
Comprehensive (income) loss attributable to noncontrolling interests | (9,323 | ) | (1,416 | ) | (15,720 | ) | 1,161 | |||||||||
Comprehensive income attributable to SVBFG | $ | 120,125 | $ | 107,495 | $ | 216,136 | $ | 286,655 |
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Total SVBFG Stockholders’ Equity | Noncontrolling Interests | Total Equity | |||||||||||||||||||||||||
(Dollars in thousands) | Shares | Amount | |||||||||||||||||||||||||||||
Balance at December 31, 2015 | 51,610,226 | $ | 52 | $ | 1,189,032 | $ | 1,993,646 | $ | 15,404 | $ | 3,198,134 | $ | 135,097 | $ | 3,333,231 | ||||||||||||||||
Common stock issued under employee benefit plans, net of restricted stock cancellations | 372,282 | — | 6,852 | — | — | 6,852 | — | 6,852 | |||||||||||||||||||||||
Common stock issued under ESOP | 43,165 | — | 4,328 | — | — | 4,328 | — | 4,328 | |||||||||||||||||||||||
Income tax effect from stock options exercised, vesting of restricted stock and other (1) | — | — | (6,587 | ) | — | — | (6,587 | ) | — | (6,587 | ) | ||||||||||||||||||||
Net income (loss) | — | — | — | 172,138 | — | 172,138 | (1,161 | ) | 170,977 | ||||||||||||||||||||||
Capital calls and distributions, net | — | — | — | — | — | — | (5,721 | ) | (5,721 | ) | |||||||||||||||||||||
Net change in unrealized gains and losses on AFS securities, net of tax | — | — | — | — | 118,610 | 118,610 | — | 118,610 | |||||||||||||||||||||||
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax | — | — | — | — | (2,879 | ) | (2,879 | ) | — | (2,879 | ) | ||||||||||||||||||||
Foreign currency translation adjustments, net of tax | — | — | — | — | (1,214 | ) | (1,214 | ) | — | (1,214 | ) | ||||||||||||||||||||
Share-based compensation, net | — | — | 16,196 | — | — | 16,196 | — | 16,196 | |||||||||||||||||||||||
Balance at June 30, 2016 | 52,025,673 | $ | 52 | $ | 1,209,821 | $ | 2,165,784 | $ | 129,921 | $ | 3,505,578 | $ | 128,215 | $ | 3,633,793 | ||||||||||||||||
Balance at December 31, 2016 | 52,254,074 | $ | 52 | $ | 1,242,741 | $ | 2,376,331 | $ | 23,430 | $ | 3,642,554 | $ | 134,483 | $ | 3,777,037 | ||||||||||||||||
Common stock issued under employee benefit plans, net of restricted stock cancellations | 419,247 | 1 | 11,821 | — | — | 11,822 | — | 11,822 | |||||||||||||||||||||||
Common stock issued under ESOP | 10,838 | — | 2,094 | — | — | 2,094 | — | 2,094 | |||||||||||||||||||||||
Income tax effect from stock options exercised, vesting of restricted stock and other (1) | — | — | — | — | — | — | — | — | |||||||||||||||||||||||
Net income | — | — | — | 224,676 | — | 224,676 | 15,720 | 240,396 | |||||||||||||||||||||||
Capital calls and distributions, net | — | — | — | — | — | — | (9,603 | ) | (9,603 | ) | |||||||||||||||||||||
Net change in unrealized gains and losses on AFS securities, net of tax | — | — | — | — | (8,047 | ) | (8,047 | ) | — | (8,047 | ) | ||||||||||||||||||||
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax | — | — | — | — | (1,994 | ) | (1,994 | ) | — | (1,994 | ) | ||||||||||||||||||||
Foreign currency translation adjustments, net of tax | — | — | — | — | 1,501 | 1,501 | — | 1,501 | |||||||||||||||||||||||
Share-based compensation, net | — | — | 26,829 | — | — | 26,829 | — | 26,829 | |||||||||||||||||||||||
Balance at June 30, 2017 | 52,684,159 | $ | 53 | $ | 1,283,485 | $ | 2,601,007 | $ | 14,890 | $ | 3,899,435 | $ | 140,600 | $ | 4,040,035 |
(1) | During the first quarter of 2017 we adopted ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. The amendments in this ASU require that all excess tax benefits and tax deficiencies associated with share-based compensation be recognized in income tax expense or benefit in the income statement. Previously, tax effects resulting from changes in the Company's share price subsequent to grant date of share-based compensation awards were recorded through additional paid-in-capital in stockholders' equity at the time of vesting and exercise. This guidance was adopted on a prospective basis with no change to prior period amounts. See Note 1—“Basis of Presentation” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for additional details. |
Six months ended June 30, | ||||||||
(Dollars in thousands) | 2017 | 2016 | ||||||
Cash flows from operating activities: | ||||||||
Net income before noncontrolling interests | $ | 240,396 | $ | 170,977 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Provision for credit losses | 46,540 | 70,221 | ||||||
Changes in fair values of equity warrant assets, net of proceeds from exercises | (9,053 | ) | (1,803 | ) | ||||
Changes in fair values of derivatives, net | 8,505 | (1,636 | ) | |||||
Gains on investment securities, net | (33,600 | ) | (18,586 | ) | ||||
Depreciation and amortization | 26,268 | 23,768 | ||||||
Amortization of premiums and discounts on investment securities, net | 1,747 | 7,923 | ||||||
Amortization of share-based compensation | 19,095 | 14,425 | ||||||
Amortization of deferred loan fees | (51,869 | ) | (46,896 | ) | ||||
Deferred income tax benefit | (9,827 | ) | (6,374 | ) | ||||
Excess tax benefit from exercise of stock options and vesting of restricted shares (1) | (13,028 | ) | — | |||||
Changes in other assets and liabilities: | ||||||||
Accrued interest receivable and payable, net | (8,852 | ) | 232 | |||||
Accounts receivable and payable, net | (6,227 | ) | (2,598 | ) | ||||
Income tax receivable and payable, net | 840 | (32,915 | ) | |||||
Accrued compensation | (51,636 | ) | (79,858 | ) | ||||
Foreign exchange spot contracts, net | 159,607 | 53,870 | ||||||
Other, net | 41,172 | (8,683 | ) | |||||
Net cash provided by operating activities | 360,078 | 142,067 | ||||||
Cash flows from investing activities: | ||||||||
Purchases of available-for-sale securities | (1,174,666 | ) | — | |||||
Proceeds from sales of available-for-sale securities | 5,024 | 2,878,272 | ||||||
Proceeds from maturities and pay downs of available-for-sale securities | 1,715,291 | 660,464 | ||||||
Purchases of held-to-maturity securities | (2,298,290 | ) | (140,641 | ) | ||||
Proceeds from maturities and pay downs of held-to-maturity securities | 806,386 | 743,117 | ||||||
Purchases of non-marketable and other securities | (9,435 | ) | (31,239 | ) | ||||
Proceeds from sales and distributions of non-marketable and other securities | 60,355 | 28,064 | ||||||
Net increase in loans | (1,066,056 | ) | (2,085,829 | ) | ||||
Purchases of premises and equipment | (21,496 | ) | (24,057 | ) | ||||
Net cash (used for) provided by investing activities | (1,982,887 | ) | 2,028,151 | |||||
Cash flows from financing activities: | ||||||||
Net increase (decrease) in deposits | 3,485,423 | (1,546,209 | ) | |||||
Net decrease in short-term borrowings | (512,198 | ) | (271,681 | ) | ||||
Principal payments of long-term debt | (46,235 | ) | — | |||||
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests | (9,603 | ) | (5,721 | ) | ||||
Tax effect from stock exercises (1) | — | (6,587 | ) | |||||
Proceeds from issuance of common stock, ESPP and ESOP | 13,916 | 11,180 | ||||||
Net cash provided by (used for) financing activities | 2,931,303 | (1,819,018 | ) | |||||
Net increase in cash and cash equivalents | 1,308,494 | 351,200 | ||||||
Cash and cash equivalents at beginning of period | 2,545,750 | 1,503,257 | ||||||
Cash and cash equivalents at end of period | $ | 3,854,244 | $ | 1,854,457 | ||||
Supplemental disclosures: | ||||||||
Cash paid during the period for: | ||||||||
Interest | $ | 22,293 | $ | 20,942 | ||||
Income taxes | 137,371 | 157,825 | ||||||
Noncash items during the period: | ||||||||
Changes in unrealized gains and losses on available-for-sale securities, net of tax | $ | (8,047 | ) | $ | 118,610 | |||
Distributions of stock from investments | 2,514 | 265 |
(1) | During the first quarter of 2017 we adopted ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. This guidance was adopted on a prospective basis with no change to prior period amounts. See Note 1—“Basis of Presentation” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for additional details. |
1. | Basis of Presentation |
2. | Stockholders’ Equity and EPS |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||||
(Dollars in thousands) | Income Statement Location | 2017 | 2016 | 2017 | 2016 | |||||||||||||
Reclassification adjustment for losses (gains) included in net income | Gains on investment securities, net | $ | 123 | $ | (12,328 | ) | $ | (485 | ) | $ | (11,582 | ) | ||||||
Related tax (benefit) expense | Income tax expense | (50 | ) | 5,017 | 198 | 4,713 | ||||||||||||
Total reclassification adjustment for losses (gains) included in net income, net of tax | $ | 73 | $ | (7,311 | ) | $ | (287 | ) | $ | (6,869 | ) |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(Dollars and shares in thousands, except per share amounts) | 2017 | 2016 | 2017 | 2016 | ||||||||||||
Numerator: | ||||||||||||||||
Net income available to common stockholders | $ | 123,193 | $ | 92,964 | $ | 224,676 | $ | 172,138 | ||||||||
Denominator: | ||||||||||||||||
Weighted average common shares outstanding—basic | 52,537 | 51,831 | 52,441 | 51,739 | ||||||||||||
Weighted average effect of dilutive securities: | ||||||||||||||||
Stock options and ESPP | 368 | 238 | 397 | 246 | ||||||||||||
Restricted stock units | 289 | 118 | 342 | 145 | ||||||||||||
Weighted average common shares outstanding—diluted | 53,194 | 52,187 | 53,180 | 52,130 | ||||||||||||
Earnings per common share: | ||||||||||||||||
Basic | $ | 2.34 | $ | 1.79 | $ | 4.28 | $ | 3.33 | ||||||||
Diluted | $ | 2.32 | $ | 1.78 | $ | 4.22 | $ | 3.30 |
Three months ended June 30, | Six months ended June 30, | |||||||||||
(Shares in thousands) | 2017 | 2016 | 2017 | 2016 | ||||||||
Stock options | 73 | 462 | 36 | 407 | ||||||||
Restricted stock units | — | 143 | — | 88 | ||||||||
Total | 73 | 605 | 36 | 495 |
3. | Share-Based Compensation |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(Dollars in thousands) | 2017 | 2016 | 2017 | 2016 | ||||||||||||
Share-based compensation expense | $ | 9,892 | $ | 7,548 | $ | 19,095 | $ | 14,425 | ||||||||
Income tax benefit related to share-based compensation expense | (3,349 | ) | (4,581 | ) | (6,364 | ) | (6,698 | ) |
(Dollars in thousands) | Unrecognized Expense | Weighted Average Expected Recognition Period - in Years | ||||
Stock options | $ | 12,309 | 2.88 | |||
Restricted stock units | 62,942 | 2.89 | ||||
Total unrecognized share-based compensation expense | $ | 75,251 |
Options | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life - in Years | Aggregate Intrinsic Value of In-The- Money Options | ||||||||||
Outstanding at December 31, 2016 | 1,010,557 | $ | 87.24 | ||||||||||
Granted | 111,855 | 178.16 | |||||||||||
Exercised | (196,006 | ) | 69.93 | ||||||||||
Forfeited | (3,662 | ) | 93.88 | ||||||||||
Outstanding at June 30, 2017 | 922,744 | 101.91 | 4.00 | $ | 68,457,617 | ||||||||
Vested and expected to vest at June 30, 2017 | 893,276 | 100.71 | 3.94 | 67,315,191 | |||||||||
Exercisable at June 30, 2017 | 568,202 | 82.89 | 2.95 | 52,783,813 |
Shares | Weighted Average Grant Date Fair Value | ||||||
Nonvested at December 31, 2016 | 670,969 | $ | 106.64 | ||||
Granted | 230,822 | 179.94 | |||||
Vested | (218,336 | ) | 102.07 | ||||
Forfeited | (16,078 | ) | 117.29 | ||||
Nonvested at June 30, 2017 | 667,377 | 133.23 |
4. | Variable Interest Entities |
(Dollars in thousands) | Consolidated VIEs | Unconsolidated VIEs | Maximum Exposure to Loss in Unconsolidated VIEs | |||||||||
June 30, 2017: | ||||||||||||
Assets: | ||||||||||||
Cash and cash equivalents | $ | 7,440 | $ | — | $ | — | ||||||
Non-marketable and other securities (1) | 194,543 | 323,426 | 323,426 | |||||||||
Accrued interest receivable and other assets | 142 | — | — | |||||||||
Total assets | $ | 202,125 | $ | 323,426 | $ | 323,426 | ||||||
Liabilities: | ||||||||||||
Other liabilities (1) | 604 | 86,545 | — | |||||||||
Total liabilities | $ | 604 | $ | 86,545 | $ | — | ||||||
December 31, 2016: | ||||||||||||
Assets: | ||||||||||||
Cash and cash equivalents | $ | 11,469 | $ | — | $ | — | ||||||
Non-marketable and other securities (1) | 196,140 | 314,810 | 314,810 | |||||||||
Accrued interest receivable and other assets | 294 | — | — | |||||||||
Total assets | $ | 207,903 | $ | 314,810 | $ | 314,810 | ||||||
Liabilities: | ||||||||||||
Other liabilities (1) | 517 | 58,095 | — | |||||||||
Total liabilities | $ | 517 | $ | 58,095 | $ | — |
(1) | Included in our unconsolidated non-marketable and other securities portfolio at June 30, 2017 and December 31, 2016 are investments in qualified affordable housing projects of $140.4 million and $112.4 million, respectively, and related unfunded credit commitments of $86.5 million and $58.1 million, respectively. |
5. | Cash and Cash Equivalents |
(Dollars in thousands) | June 30, 2017 | December 31, 2016 | ||||||
Cash and due from banks (1) | $ | 3,658,927 | $ | 2,476,588 | ||||
Securities purchased under agreements to resell (2) | 192,421 | 64,028 | ||||||
Other short-term investment securities | 2,896 | 5,134 | ||||||
Total cash and cash equivalents | $ | 3,854,244 | $ | 2,545,750 |
(1) | At June 30, 2017 and December 31, 2016, $1.8 billion and $1.1 billion, respectively, of our cash and due from banks was deposited at the Federal Reserve Bank and was earning interest at the Federal Funds target rate, and interest-earning deposits in other financial institutions were $1.2 billion and $721 million, respectively. |
(2) | At June 30, 2017 and December 31, 2016, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $196 million and $66 million, respectively. None of these securities were sold or repledged as of June 30, 2017 and December 31, 2016. |
6. | Investment Securities |
June 30, 2017 | ||||||||||||||||
(Dollars in thousands) | Amortized Cost | Unrealized Gains | Unrealized Losses | Carrying Value | ||||||||||||
Available-for-sale securities, at fair value: | ||||||||||||||||
U.S. Treasury securities | $ | 7,785,838 | $ | 19,443 | $ | (3,599 | ) | $ | 7,801,682 | |||||||
U.S. agency debentures | 1,917,475 | 11,355 | (1,577 | ) | 1,927,253 | |||||||||||
Residential mortgage-backed securities: | ||||||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 1,925,216 | 3,885 | (13,820 | ) | 1,915,281 | |||||||||||
Agency-issued collateralized mortgage obligations—variable rate | 418,173 | 1,361 | (147 | ) | 419,387 | |||||||||||
Equity securities | 6,603 | 1,495 | (649 | ) | 7,449 | |||||||||||
Total available-for-sale securities | $ | 12,053,305 | $ | 37,539 | $ | (19,792 | ) | $ | 12,071,052 |
December 31, 2016 | ||||||||||||||||
(Dollars in thousands) | Amortized Cost | Unrealized Gains | Unrealized Losses | Carrying Value | ||||||||||||
Available-for-sale securities, at fair value: | ||||||||||||||||
U.S. Treasury securities | $ | 8,880,358 | $ | 30,323 | $ | (1,190 | ) | $ | 8,909,491 | |||||||
U.S. agency debentures | 2,065,535 | 14,443 | (1,603 | ) | 2,078,375 | |||||||||||
Residential mortgage-backed securities: | ||||||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 1,163,017 | 3,046 | (13,398 | ) | 1,152,665 | |||||||||||
Agency-issued collateralized mortgage obligations—variable rate | 474,238 | 685 | (640 | ) | 474,283 | |||||||||||
Equity securities | 5,635 | 748 | (786 | ) | 5,597 | |||||||||||
Total available-for-sale securities | $ | 12,588,783 | $ | 49,245 | $ | (17,617 | ) | $ | 12,620,411 |
June 30, 2017 | ||||||||||||||||||||||||
Less than 12 months | 12 months or longer | Total | ||||||||||||||||||||||
(Dollars in thousands) | Fair Value of Investments | Unrealized Losses | Fair Value of Investments | Unrealized Losses | Fair Value of Investments | Unrealized Losses | ||||||||||||||||||
Available-for-sale securities: | ||||||||||||||||||||||||
U.S. Treasury securities | $ | 2,724,519 | $ | (3,599 | ) | $ | — | $ | — | $ | 2,724,519 | $ | (3,599 | ) | ||||||||||
U.S. agency debentures | 762,920 | (1,577 | ) | — | — | 762,920 | (1,577 | ) | ||||||||||||||||
Residential mortgage-backed securities: | ||||||||||||||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 851,825 | (7,849 | ) | 201,986 | (5,971 | ) | 1,053,811 | (13,820 | ) | |||||||||||||||
Agency-issued collateralized mortgage obligations—variable rate | 6,185 | (14 | ) | 69,706 | (133 | ) | 75,891 | (147 | ) | |||||||||||||||
Equity securities | 3,561 | (649 | ) | — | — | 3,561 | (649 | ) | ||||||||||||||||
Total temporarily impaired securities (1) | $ | 4,349,010 | $ | (13,688 | ) | $ | 271,692 | $ | (6,104 | ) | $ | 4,620,702 | $ | (19,792 | ) |
(1) | As of June 30, 2017, we identified a total of 184 investments that were in unrealized loss positions, of which 44 investments totaling $271.7 million with unrealized losses of $6.1 million have been in an impaired position for a period of time greater than 12 months. As of June 30, 2017, we do not intend to sell any impaired fixed income investment securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis. Based on our analysis as of June 30, 2017, we deem all impairments to be temporary, and therefore changes in value for our temporarily impaired securities as of the same date are included in other comprehensive income. Market valuations and impairment analyses on assets in the available-for-sale securities portfolio are reviewed and monitored on a quarterly basis. |
December 31, 2016 | ||||||||||||||||||||||||
Less than 12 months | 12 months or longer | Total | ||||||||||||||||||||||
(Dollars in thousands) | Fair Value of Investments | Unrealized Losses | Fair Value of Investments | Unrealized Losses | Fair Value of Investments | Unrealized Losses | ||||||||||||||||||
Available-for-sale securities: | ||||||||||||||||||||||||
U.S. Treasury securities | $ | 879,255 | $ | (1,190 | ) | $ | — | $ | — | $ | 879,255 | $ | (1,190 | ) | ||||||||||
U.S. agency debentures | 513,198 | (1,603 | ) | — | — | 513,198 | (1,603 | ) | ||||||||||||||||
Residential mortgage-backed securities: | ||||||||||||||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 635,566 | (6,704 | ) | 227,480 | (6,694 | ) | 863,046 | (13,398 | ) | |||||||||||||||
Agency-issued collateralized mortgage obligations—variable rate | 258,325 | (613 | ) | 6,068 | (27 | ) | 264,393 | (640 | ) | |||||||||||||||
Equity securities | 3,693 | (786 | ) | — | — | 3,693 | (786 | ) | ||||||||||||||||
Total temporarily impaired securities (1) | $ | 2,290,037 | $ | (10,896 | ) | $ | 233,548 | $ | (6,721 | ) | $ | 2,523,585 | $ | (17,617 | ) |
(1) | As of December 31, 2016, we identified a total of 174 investments that were in unrealized loss positions, of which 20 investments totaling $233.5 million with unrealized losses of $6.7 million have been in an impaired position for a period of time greater than 12 months. |
June 30, 2017 | ||||||||||||||||||||
(Dollars in thousands) | Total | One Year or Less | After One Year to Five Years | After Five Years to Ten Years | After Ten Years | |||||||||||||||
U.S. Treasury securities | $ | 7,801,682 | $ | 2,144,571 | $ | 5,657,111 | $ | — | $ | — | ||||||||||
U.S. agency debentures | 1,927,253 | 424,613 | 1,502,640 | — | — | |||||||||||||||
Residential mortgage-backed securities: | ||||||||||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 1,915,281 | — | — | 554,866 | 1,360,415 | |||||||||||||||
Agency-issued collateralized mortgage obligations—variable rate | 419,387 | — | — | — | 419,387 | |||||||||||||||
Total | $ | 12,063,603 | $ | 2,569,184 | $ | 7,159,751 | $ | 554,866 | $ | 1,779,802 |
June 30, 2017 | ||||||||||||||||
(Dollars in thousands) | Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | ||||||||||||
Held-to-maturity securities, at cost: | ||||||||||||||||
U.S. agency debentures (1) | $ | 641,191 | $ | 7,553 | $ | (1,291 | ) | $ | 647,453 | |||||||
Residential mortgage-backed securities: | ||||||||||||||||
Agency-issued mortgage-backed securities | 4,170,585 | 12,047 | (14,619 | ) | 4,168,013 | |||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 3,240,643 | 853 | (26,227 | ) | 3,215,269 | |||||||||||
Agency-issued collateralized mortgage obligations—variable rate | 283,519 | 581 | (57 | ) | 284,043 | |||||||||||
Agency-issued commercial mortgage-backed securities | 1,386,455 | 2,507 | (9,267 | ) | 1,379,695 | |||||||||||
Municipal bonds and notes | 215,978 | 1,451 | (1,398 | ) | 216,031 | |||||||||||
Total held-to-maturity securities | $ | 9,938,371 | $ | 24,992 | $ | (52,859 | ) | $ | 9,910,504 |
(1) | Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States. |
December 31, 2016 | ||||||||||||||||
(Dollars in thousands) | Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | ||||||||||||
Held-to-maturity securities, at cost: | ||||||||||||||||
U.S. agency debentures (1) | $ | 622,445 | $ | 7,840 | $ | (1,198 | ) | $ | 629,087 | |||||||
Residential mortgage-backed securities: | ||||||||||||||||
Agency-issued mortgage-backed securities | 2,896,179 | 6,919 | (24,526 | ) | 2,878,572 | |||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 3,362,598 | 788 | (31,274 | ) | 3,332,112 | |||||||||||
Agency-issued collateralized mortgage obligations—variable rate | 312,665 | 176 | (1,339 | ) | 311,502 | |||||||||||
Agency-issued commercial mortgage-backed securities | 1,151,363 | 1,237 | (7,638 | ) | 1,144,962 | |||||||||||
Municipal bonds and notes | 81,748 | 8 | (1,853 | ) | 79,903 | |||||||||||
Total held-to-maturity securities | $ | 8,426,998 | $ | 16,968 | $ | (67,828 | ) | $ | 8,376,138 |
(1) | Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States. |
June 30, 2017 | ||||||||||||||||||||||||
Less than 12 months | 12 months or longer | Total | ||||||||||||||||||||||
(Dollars in thousands) | Fair Value of Investments | Unrealized Losses | Fair Value of Investments | Unrealized Losses | Fair Value of Investments | Unrealized Losses | ||||||||||||||||||
Held-to-maturity securities: | ||||||||||||||||||||||||
U.S. agency debentures | $ | 63,160 | $ | (1,291 | ) | $ | — | $ | — | $ | 63,160 | $ | (1,291 | ) | ||||||||||
Residential mortgage-backed securities: | ||||||||||||||||||||||||
Agency-issued mortgage-backed securities | 2,242,392 | (13,972 | ) | 20,690 | (647 | ) | 2,263,082 | (14,619 | ) | |||||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate | 2,719,351 | (21,887 | ) | 201,313 | (4,340 | ) | 2,920,664 | (26,227 | ) | |||||||||||||||
Agency-issued collateralized mortgage obligations—variable rate | — | — |